These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

181 related items for PubMed ID: 2063840

  • 1. Can the nephrologist prevent dialysis-related amyloidosis?
    Zingraff J, Drüeke T.
    Am J Kidney Dis; 1991 Jul; 18(1):1-11. PubMed ID: 2063840
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [Beta 2-microglobulin and dialysis-related amyloidosis].
    Gejyo F.
    Rinsho Byori; 2001 Mar; 49(3):244-8. PubMed ID: 11307323
    [Abstract] [Full Text] [Related]

  • 4. Beta 2-microglobulin associated amyloidosis and therapy with high flux hemodialysis membranes.
    Floege J, Koch KM.
    Clin Nephrol; 1994 Jul; 42 Suppl 1():S52-6. PubMed ID: 7923985
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Haemodialysis-associated beta 2M amyloidosis: current controversies.
    Stein G, Sperschneider H, Fünfstück R, Ritz E.
    Nephrol Dial Transplant; 1994 Jul; 9 Suppl 3():48-50. PubMed ID: 8072726
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. High-efficiency dialysis with PMMA dialyzers: treatment dose delivery and long-term results.
    David S, Cambi V.
    Contrib Nephrol; 1999 Jul; 125():96-110. PubMed ID: 9895434
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Pathogenesis and management of dialysis-related amyloid bone disease.
    Nangaku M, Miyata T, Kurokawa K.
    Am J Med Sci; 1999 Jun; 317(6):410-5. PubMed ID: 10372842
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. beta2-microglobulin-derived amyloidosis: an update.
    Floege J, Ketteler M.
    Kidney Int Suppl; 2001 Feb; 78():S164-71. PubMed ID: 11169004
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Nontransplant therapy for dialysis-related amyloidosis.
    Copley JB, Lindberg JS.
    Semin Dial; 2001 Feb; 14(2):94-8. PubMed ID: 11264774
    [Abstract] [Full Text] [Related]

  • 17. [Amyloidosis associated with dialysis].
    Mátyus J, Kakuk G.
    Orv Hetil; 1995 Mar 12; 136(11):587-93. PubMed ID: 7700615
    [Abstract] [Full Text] [Related]

  • 18. Scintigraphic methods to detect beta2-microglobulin associated amyloidosis (Abeta2-microglobulin amyloidosis).
    Floege J, Schäffer J, Koch KM.
    Nephrol Dial Transplant; 2001 Mar 12; 16 Suppl 4():12-6. PubMed ID: 11402091
    [Abstract] [Full Text] [Related]

  • 19. New aspects in the pathogenesis of dialysis-related amyloidosis: pathophysiology of advanced glycation end products in renal failure.
    Miyata T.
    Nihon Jinzo Gakkai Shi; 1996 May 12; 38(5):191-7. PubMed ID: 8699608
    [Abstract] [Full Text] [Related]

  • 20. Amyloidosis and its relationship to different dialysers.
    van Ypersele de Strihou C, Floege J, Jadoul M, Koch KM.
    Nephrol Dial Transplant; 1994 May 12; 9 Suppl 2():156-61. PubMed ID: 8065608
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.